OpenURL Connection Search

Select item for more details and to access through your institution.

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
Published in:
2020
By:
- Privé, Bastiaan M.;
- Janssen, Marcel J. R.;
- van Oort, Inge M.;
- Muselaers, Constantijn H. J.;
- Jonker, Marianne A.;
- de Groot, Michel;
- Mehra, Niven;
- Verzijlbergen, J. Fred;
- Scheenen, Tom W. J.;
- Zámecnik, Patrik;
- Barentsz, Jelle O.;
- Gotthardt, Martin;
- Noordzij, Walter;
- Vogel, Wouter V.;
- Bergman, Andries M.;
- van der Poel, Henk G.;
- Vis, André N.;
- Oprea-Lager, Daniela E.;
- Gerritsen, Winald R.;
- Witjes, J. Alfred
Publication type:
journal article
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.
Published in:
EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-00952-z
By:
- Peters, Steffie M. B.;
- Mink, Maaike C. T.;
- Privé, Bastiaan M.;
- de Bakker, Maarten;
- de Lange, Frank;
- Muselaers, Constantijn H. J.;
- Mehra, Niven;
- Witjes, J. Alfred;
- Gotthardt, Martin;
- Nagarajah, James;
- Konijnenberg, Mark W.
Publication type:
Article
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.
Published in:
Cancers, 2023, v. 15, n. 1, p. 297, doi. 10.3390/cancers15010297
By:
- Banda, Amina;
- Privé, Bastiaan M.;
- Allach, Youssra;
- Uijen, Maike J. M.;
- Peters, Steffie M. B.;
- Loeff, Cato C.;
- Gotthardt, Martin;
- Muselaers, Constantijn H. J.;
- Witjes, J. Alfred;
- van Oort, Inge M.;
- Sedelaar, J. P. Michiel;
- Westdorp, Harm;
- Mehra, Niven;
- Khreish, Fadi;
- Ezziddin, Samer;
- Sabet, Amir;
- Kreissl, Michael C.;
- Winkens, Thomas;
- Seifert, Philipp;
- Janssen, Marcel J. R.
Publication type:
Article
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.
Published in:
EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00636-0
By:
- Grob, Dagmar;
- Privé, Bastiaan M.;
- Muselaers, Constantijn H. J.;
- Mehra, Niven;
- Nagarajah, James;
- Konijnenberg, Mark W.;
- Peters, Steffie M. B.
Publication type:
Article
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
Published in:
2021
By:
- Privé, Bastiaan M.;
- Janssen, Marcel J. R.;
- van Oort, Inge M.;
- Muselaers, Constantijn H. J.;
- Jonker, Marianne A.;
- van Gemert, Willemijn A.;
- de Groot, Michel;
- Westdorp, Harm;
- Mehra, Niven;
- Verzijlbergen, J. Fred;
- Scheenen, Tom W. J.;
- Zámecnik, Patrik;
- Barentsz, Jelle O.;
- Gotthardt, Martin;
- Noordzij, Walter;
- Vogel, Wouter V.;
- Bergman, Andries M.;
- van der Poel, Henk G.;
- Vis, André N.;
- Oprea-Lager, Daniela E.
Publication type:
Letter
Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Published in:
Journal of Nuclear Medicine, 2014, v. 55, n. 6, p. 1035, doi. 10.2967/jnumed.114.137356
By:
- Muselaers, Constantijn H. J.;
- Stillebroer, Alexander B.;
- Rijpkema, Mark;
- Franssen, Gerben M.;
- Oosterwijk, Egbert;
- Mulders, Peter F. A.;
- Oyen, Wim J. G.;
- Boerman, Otto C.
Publication type:
Article
Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma.
Published in:
Journal of Nuclear Medicine, 2014, v. 55, n. 2, p. 242, doi. 10.2967/jnumed.113.131110
By:
- Muselaers, Constantijn H. J.;
- Stillebroer, Alexander B.;
- Desar, Ingrid M. E.;
- Boers-Sonderen, Marye J.;
- van Herpen, Carla M. L.;
- de Weijert, Mirjam C. A.;
- Langenhuijsen, Johan F.;
- Oosterwijk, Egbert;
- Leenders, William P. J.;
- Boerman, Otto C.;
- Mulders, Peter F. A.;
- Oyen, Wim J. G.
Publication type:
Article
Theranostics in prostaatkanker.
Published in:
Tijdschrift voor Urologie, 2024, v. 14, n. 2/3, p. 63, doi. 10.1007/s13629-024-00423-7
By:
- Privé, Bastiaan M.;
- Muselaers, Constantijn H. J.;
- Peters, Steffie M. B.;
- Timmermans, Bart;
- Westdorp, Harm;
- Franken, Mira D.;
- Vis, André N.;
- Janssen, Marcel J. R.;
- Oprea-Lager, Daniela E.;
- Nagarajah, James
Publication type:
Article
Case report. Hematurie bij een patiënt met lokale doorgroei van een testiscarcinoom.
Published in:
Tijdschrift voor Urologie, 2023, v. 13, n. 5, p. 117, doi. 10.1007/s13629-023-00393-2
By:
- Nuijens, Siberyn T.;
- Mulder, Sasja F.;
- Halilovic, Mirha;
- Sijm, Joost H. M.;
- Muselaers, Constantijn H. J.
Publication type:
Article
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives.
Published in:
Diagnostics (2075-4418), 2023, v. 13, n. 13, p. 2294, doi. 10.3390/diagnostics13132294
By:
- Distante, Alfredo;
- Marandino, Laura;
- Bertolo, Riccardo;
- Ingels, Alexandre;
- Pavan, Nicola;
- Pecoraro, Angela;
- Marchioni, Michele;
- Carbonara, Umberto;
- Erdem, Selcuk;
- Amparore, Daniele;
- Campi, Riccardo;
- Roussel, Eduard;
- Caliò, Anna;
- Wu, Zhenjie;
- Palumbo, Carlotta;
- Borregales, Leonardo D.;
- Mulders, Peter;
- Muselaers, Constantijn H. J.
Publication type:
Article
[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 4, p. 1101, doi. 10.1007/s00259-021-05538-2
By:
- Peters, Steffie M. B.;
- Hofferber, Regina;
- Privé, Bastiaan M.;
- de Bakker, Maarten;
- Gotthardt, Martin;
- Janssen, Marcel;
- de Lange, Frank;
- Muselaers, Constantijn H. J.;
- Mehra, Niven;
- Witjes, J. Alfred;
- Costa, Pedro F.;
- Nagarajah, James;
- Konijnenberg, Mark W.;
- Jentzen, Walter
Publication type:
Article
[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 4, p. 1101, doi. 10.1007/s00259-021-05538-2
By:
- Peters, Steffie M. B.;
- Hofferber, Regina;
- Privé, Bastiaan M.;
- de Bakker, Maarten;
- Gotthardt, Martin;
- Janssen, Marcel;
- de Lange, Frank;
- Muselaers, Constantijn H. J.;
- Mehra, Niven;
- Witjes, J. Alfred;
- Costa, Pedro F.;
- Nagarajah, James;
- Konijnenberg, Mark W.;
- Jentzen, Walter
Publication type:
Article
Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 2, p. 460, doi. 10.1007/s00259-021-05471-4
By:
- Peters, Steffie M. B.;
- Privé, Bastiaan M.;
- de Bakker, Maarten;
- de Lange, Frank;
- Jentzen, Walter;
- Eek, Annemarie;
- Muselaers, Constantijn H. J.;
- Mehra, Niven;
- Witjes, J. Alfred;
- Gotthardt, Martin;
- Nagarajah, James;
- Konijnenberg, Mark W.
Publication type:
Article
Optimizing Lutetium 177--Anti--Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model.
Published in:
Molecular Imaging, 2014, v. 13, n. 4, p. 1, doi. 10.2310/7290.2014.00008
By:
- Muselaers, Constantijn H. J.;
- Oosterwijk, Egbert;
- Bos, Desiree L.;
- Oyen, Wim J. G.;
- Mulders, Peter F. A.;
- Boerman, Otto C.
Publication type:
Article

Found: 14

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.

Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.

PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.

Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.

Tyrosine Kinase Inhibitor Sorafenib Decreases <sup>111</sup>In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma.

Theranostics in prostaatkanker.

Case report. Hematurie bij een patiënt met lokale doorgroei van een testiscarcinoom.

Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives.

[<sup>68</sup>Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [<sup>177</sup>Lu]Lu-PSMA-617 treatment.

[<sup>68</sup>Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [<sup>177</sup>Lu]Lu-PSMA-617 treatment.

Intra-therapeutic dosimetry of [<sup>177</sup>Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome.

Optimizing Lutetium 177--Anti--Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model.